Trials / Recruiting
RecruitingNCT06636474
Evaluation of the Supported Housing System for the Inclusion of People Suffering From Mental Disorders
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Centre Hospitalier St Anne · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Access to housing, in the current context of extreme tension in the rental housing market in Paris and throughout the Ile-de-France region, is proving to be extremely complex for people with mental health problems.National and international scientific studies have quantified the problem of homelessness and precarious or inappropriate housing among patients suffering from psychiatric disorders, and show the impact of housing problems on the consumption of psychiatric care.The DÉLAI's mission is to facilitate access to housing for people enrolled in a psychiatric care pathway, with teams from the psychiatric sectors
Detailed description
* Written and oral information provided to the patient by the patient's referring psychiatrist (Investigator of one of the five recruiting sites) during a regular consultation appointment. * Initial assessment (V inclusion): reminder of the information concerning the research, collection of consent, collection of sociodemographic data, and standardized assessment scales (quality of life, clinical state, level of functioning) + standardized semi-structured interview for the diagnosis of psychiatric disorders + completion by the referring psychiatrist of the data corresponding to the patient's care pathway. * Then follow-up visit at an annual rate (V1 ... VX), and DLAI exit assessment (V exit) as soon as the patient stops benefiting from the DLAI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | patients with mental disorders | administration of standardized questionnaires and scales, upon entering the research, then annually, and finally upon leaving the research |
Timeline
- Start date
- 2020-07-27
- Primary completion
- 2030-07-27
- Completion
- 2030-12-27
- First posted
- 2024-10-10
- Last updated
- 2024-10-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06636474. Inclusion in this directory is not an endorsement.